Evidence map›Paper›PMID 41704219›Full record

ArticleJournal of applied clinical medical physics2026

Developing an automatic decision-assistance tool to choose proton/photon radiotherapy for patients with prostate cancer.

Mengyang Li, Linyi Shen, Xinyuan Chen, Guiyuan Li, Jialin Ding, Kuo Men, Junlin Yi, Jianrong Dai

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mengyang LiNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Linyi ShenNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xinyuan ChenNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Guiyuan LiNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jialin DingNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Kuo MenNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Junlin YiNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jianrong DaiNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Funding

CAMS Innovation Fund for Medical Sciences CIFMS,2024-I2M-C&T-A-002National High Level Hospital Clinical Research Funding 2022-CICAMS-80102022203National High Level Hospital Clinical Research Funding 2025-LYZX-Z-B05National Key R&D Program of China 2023YFC2411600National Natural Science Foundation of China 12275357
6 · The paper itself

Abstract

purposeIt is important to guide staff in choosing appropriately between photon and proton radiotherapy. This study develops an automatic decision method to select the most clinically beneficial radiotherapy technique (proton or photon) for patients with prostate cancer. An automatic decision method was developed to help staff in choosing appropriately between photon and proton radiotherapy for patients with prostate cancer. MATERIALS AND

methodsForty-eight patients with prostate cancer were enrolled. First, photon and proton dose prediction models (M

resultsThe deep learning (DL) model showed a mean absolute error (MAE) of 4.60 ± 1.80 for the rectum wall in the photon group and 3.64 ± 1.27 in the proton group. There was no statistically significant difference in V

conclusionThe proposed automatic decision method matches dose distributions, accurately calculates NTCPs, and supports precise radiotherapy technique selection, enhancing the clinical efficiency.

Indexed as

Deep LearningPhotonsProstatic NeoplasmsProton TherapyRadiotherapy Planning, Computer-AssistedAgedHumansMaleOrgans at RiskRadiotherapy DosageRadiotherapy, Intensity-Modulatedautomatic decision methoddeep learningNTCPphoton therapyprostate cancerproton therapy

Identifiers

PMID41704219
PMCPMC12914344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.